Highlights A randomized, placebo-controlled, Phase 3 trial demonstrated the safety and efficacy of MDMA-assisted therapy for the treatment of severe posttraumatic stress disorder (PTSD) Participants met …
The highly statistically significant results and excellent safety record suggest MDMA-assisted therapy will be approved as effective treatment for severe, chronic PTSD in 2023. 67% of participants who …
Widespread anecdotal reports of benefit have led to self-treatment of the symptoms of PTSD with cannabis among Veterans and others; the safety and potential efficacy of such treatments have not previously …
FOR IMMEDIATE RELEASEDecember 7, 2020 Cognitive-behavioral conjoint therapy (CBCT) for posttraumatic stress disorder (PTSD), when combined with MDMA, resulted in significant improvements in PTSD symptoms …
Pilot study explored the application of MDMA-assisted psychotherapy in 18 individuals experiencing moderate to severe anxiety following diagnosis with a life-threatening illness. The primary outcome, change …
Today, the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) announced the publication of the long-term follow-up results of six Phase 2 clinical trials of MDMA-assisted psychotherapy …
PRESS RELEASE: Psychopharmacology Publishes Combined Analysis of Phase 2 Clinical Trials of MDMA-Assisted Therapy for PTSD CONTACT: Betty Aldworth, Director of Communications and Events, MAPS Media Requests: …
PRESS RELEASE: MDMA-Assisted Therapy Shows Promise for Reducing Social Anxiety in Autistic Adults, New Study Shows Results published in Psychopharmacology CONTACT: Brad Burge, Director of Strategic Communications, …
PRESS RELEASE: MDMA-Assisted Therapy Shows Promise for Veterans with Chronic, Treatment-Resistant PTSD • Results published in The Lancet Psychiatry CONTACT: Brad Burge, Director of Strategic Communications, …
Observational research published in American Journal of Drug and Alcohol Abuse CONTACT:Brad Burge, Director of Communications and Marketing, MAPSMedia Requests:Press Resources: Ismail Ali, Policy Fellow, …
On March 25, 2015, a paper presenting the rationale for our ongoing study of MDMA-assisted therapy for the treatment of social anxiety in autistic adults was published in the peer-reviewed journal Progress …
